In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients | Zendy

Shuwen Deng | Zendy; Sybren de Hoog | Zendy; Paul E. Verweij | Zendy; Jan Zoll | Zendy; Macit İlkit | Zendy; Farhad Morsali | Zendy; Paride Abliz | Zendy; X. Wang | Zendy; Ping Zhan | Zendy; Lu Yang | Zendy; Hadiliya Hasimu | Zendy; Wanqing Liao | Zendy; Weihua Pan | Zendy; Seyedmojtaba Seyedmousavi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients

Author(s) -

Shuwen Deng,

Sybren de Hoog,

Paul E. Verweij,

Jan Zoll,

Macit İlkit,

Farhad Morsali,

Paride Abliz,

X. Wang,

Ping Zhan,

Lu Yang,

Hadiliya Hasimu,

Wanqing Liao,

Weihua Pan,

Seyedmojtaba Seyedmousavi

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku503

Subject(s) - tinea capitis , posaconazole , voriconazole , terbinafine , itraconazole , fluconazole , medicine , dermatophyte , microbiology and biotechnology , broth microdilution , trichophyton , dermatology , biology , antifungal , minimum inhibitory concentration , antibiotics

Trichophyton violaceum is an anthropophilic dermatophyte that is endemic to parts of Africa and Asia and is sporadic in Europe. T. violaceum mainly causes tinea capitis in both children and adolescents. Although the infections caused by T. violaceum are of considerable medical importance, its antifungal susceptibility profile remains poorly examined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research